10x Genomics acquires Epinomics, Inc.

10x Genomics acquired Epinomics, Inc., a transaction completed in August 2018, structured as Stock/asset acquisition (terms not disclosed).

Epinomics, Inc. operates in Epigenetics / Single Cell, is based in California, United States. Acquisition of Epinomics, Inc., a California-based epigenetics company founded by the team that developed the ATAC-seq technology, giving 10x Genomics foundational ATAC-seq technology and intellectual property. This was 10x Genomics' first acquisition.

Accelerate discoveries in epigenomics and provide a foundation for new products; technology was immediately integrated into 10x's Chromium Single Cell ATAC Solution.

ATAC-seq IP and technology integrated into 10x's Chromium Single Cell ATAC Solution. Chromium Single Cell platform